Insider Transactions Reported by 17 Insiders of Lyra Therapeutics, Inc.

Symbol
LYRA on Nasdaq
Location
Watertown, MA

Insiders trading volume in the past year

Lyra Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
NBVM GP, LLC 10%+ Owner $7,473,948 31 May 2023
Maria Palasis President & CEO, Director $3,689,409 -$19,670 -0.53% 06 Jan 2026
Jason Cavalier Chief Financial Officer $1,744,392 -$8,681 -0.5% 06 Jan 2026
Harlan Waksal Executive Chair, Director $1,591,460 09 Dec 2024
Corinne Noyes SVP of Commercial Strategy and Market Development $108,674 31 Jan 2023
Robert E. Richard SVP, Technical Operations $88,914 31 Jan 2023
PERCEPTIVE ADVISORS LLC 10%+ Owner $54,702 -$526,734 -91% 11 Nov 2025
MICHAEL SETH ALTMAN Director 13 Jun 2024
Richard Nieman Chief Medical Officer 30 Jan 2024
W. Bradford Smith Director 14 May 2025
John E. Bishop Chief Technology Officer 30 Jan 2024
JAMES R. TOBIN Director 14 May 2025
C. ANN MERRIFIELD Director 14 May 2025
Pamela E. Nelson SVP, Regulatory Affairs 12 Feb 2022
nancy lynn snyderman MD Director 14 May 2025
ANDERSON EDWARD T. Director, 10%+ Owner 30 Jun 2023
Konstantin Poukalov Director 13 Jun 2024

Recent Insider Transactions by Companies or Individuals for Lyra Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.